Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +5.10% |
|
+1.48% | -4.63% |
Jun. 17 | MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. | CI |
May. 23 | MyMD Pharmaceuticals, Inc. amended terms of the transaction | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 50.93M |
---|---|---|---|---|---|
Net income 2022 | -4M | Net income 2023 | -4M | EV / Sales 2022 | - |
Net cash position 2022 | 85.4M | Net cash position 2023 | 68.04M | EV / Sales 2023 | - |
P/E ratio 2022 |
-8.53
x | P/E ratio 2023 |
-13.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.95% |
1 day | +5.10% | ||
1 week | +1.48% | ||
Current month | +5.10% | ||
1 month | +5.10% | ||
3 months | -16.94% | ||
6 months | -5.72% | ||
Current year | -4.63% |
![Extreme 1.96](/images/extremecours_fleche.png)
![Extreme 1.88](/images/extremecours_fleche.png)
![Extreme 1.76](/images/extremecours_fleche.png)
![Extreme 1.76](/images/extremecours_fleche.png)
![Extreme 1.76](/images/extremecours_fleche.png)
![Extreme 1.76](/images/extremecours_fleche.png)
![Extreme 1.76](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 14-12-31 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 20-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 22-11-13 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 22-08-14 |
Wayne Walker
BRD | Director/Board Member | 65 | 22-12-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 2.06 | +5.10% | 9,869 |
24-07-01 | 1.96 | +0.01% | 15,421 |
24-06-28 | 1.96 | -5.77% | 18,853 |
24-06-27 | 2.08 | +3.48% | 5,441 |
24-06-26 | 2.01 | -0.99% | 5,161 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.63% | 17.41M | |
+55.55% | 816B | |
+42.31% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+14.02% | 238B | |
+1.64% | 222B | |
+13.66% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- PMCB Stock